PTSM: Pharmaceutical Technology Sourcing and Management
Production of kilogram-scale batches of synthetic molecules for early-stage development are now available to US customers.
Novasep has finalized the set-up of its new synthesis laboratory and kilogram-scale laboratory at its Pennsylvania, US facility. Production of kilogram-scale batches of synthetic molecules for biological testing and preclinical trials has begun.â¨
“Drug developers in the US are responding positively to our extended CMO services that support their early stage programs," said Andrew Brennan, general manager at Novasep’s US operations, in a press release.
“The proximity to our US experts will help to secure and speed up our customers’ projects. And beyond the technical expertise of our team, the trusted partnerships that Novasep is building with US companies will promote future development and commercial supply agreements to keep up with the fast growing US pharmaceutical market,” said Thierry Van Nieuwenhove, Synthesis BU president.
The facility in Boothwyn, PA is equipped with jacketed reactors ranging from 100 mL to 50 L in size and with a 3 5L filter dryer for isolation of kilogram quantities of compound. The laboratory extension has equipment for standard and cryogenic chemistry. For purification services, the laboratory provides North American customers with Novasep’s preparative chromatography technologies and has analytical tools for process research and development, including a calorimetric reactor for preliminary process safety testing.â¨
Source: Novasep
Drug Solutions Podcast: Gliding Through the Ins and Outs of the Pharma Supply Chain
November 14th 2023In this episode of the Drug Solutions podcast, Jill Murphy, former editor, speaks with Bourji Mourad, partnership director at ThermoSafe, about the supply chain in the pharmaceutical industry, specifically related to packaging, pharma air freight, and the pressure on suppliers with post-COVID-19 changes on delivery.
Drug Solutions Podcast: Emerging Methods of Vaccine Administration and Distribution
June 20th 2023Michael Schrader, CEO and co-founder of Vaxess, discusses the latest on vaccine administration and different ways the pharmaceutical industry can distribute these products with Pharmaceutical Technology editor Jill Murphy.